Matches in DBpedia 2014 for { <http://dbpedia.org/resource/PF-184563> ?p ?o. }
Showing items 1 to 37 of
37
with 100 items per page.
- PF-184563 abstract "PF-184563 is a potent, selective non-peptidic antagonist of the V1a receptor. The compound was discovered by Pfizer in its Sandwich, Kent research center, as a potential treatment for dysmenorrhoea, an indication for which V1a antagonists have shown efficacy.".
- PF-184563 atcPrefix "none".
- PF-184563 bioavailability "34.0".
- PF-184563 casNumber "748806-39-5".
- PF-184563 iupacName "8-Chloro-5-methyl-1-(3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulene".
- PF-184563 thumbnail PF-184563.png?width=300.
- PF-184563 wikiPageID "33175636".
- PF-184563 wikiPageRevisionID "592772816".
- PF-184563 atcPrefix "none".
- PF-184563 bioavailability "34.0".
- PF-184563 c "21".
- PF-184563 casNumber "748806".
- PF-184563 chembl "1837037".
- PF-184563 cl "1".
- PF-184563 clogp "2.1".
- PF-184563 eliminationHalfLife "6480.0".
- PF-184563 h "23".
- PF-184563 hasPhotoCollection PF-184563.
- PF-184563 iupacName "8".
- PF-184563 molecularWeight "394.91".
- PF-184563 n "6".
- PF-184563 proteinBound "69.0".
- PF-184563 verifiedfields "changed".
- PF-184563 verifiedrevid "452024825".
- PF-184563 width "220".
- PF-184563 subject Category:Hormonal_agents.
- PF-184563 subject Category:Pfizer.
- PF-184563 type Drug.
- PF-184563 type FunctionalSubstance.
- PF-184563 comment "PF-184563 is a potent, selective non-peptidic antagonist of the V1a receptor. The compound was discovered by Pfizer in its Sandwich, Kent research center, as a potential treatment for dysmenorrhoea, an indication for which V1a antagonists have shown efficacy.".
- PF-184563 label "PF-184563".
- PF-184563 sameAs m.0h6927p.
- PF-184563 sameAs Q7119046.
- PF-184563 sameAs Q7119046.
- PF-184563 wasDerivedFrom PF-184563?oldid=592772816.
- PF-184563 depiction PF-184563.png.
- PF-184563 isPrimaryTopicOf PF-184563.